"Random high" trial data misleads; BioClinica to consume TranSenda;

> In trials ended early due to better-than-expected results, researchers may have caught data at a "random high"--the appearance of a big effect that may lessen over time. Article

> Service provider BioClinica is acquiring TranSenda, maker of the MS Office-interoperable Office-Smart clinical trial management system. Release

> Both trial recruitment and retention materials need to evoke an emotional response, but retention messages must also reinforce a tie to the study and show subjects the significance of their commitment. Article

> An unnamed tissue-regeneration company is randomizing subjects and collecting data in the operating room via DATATRAK's eClinical platform. Announcement

> A Tufts study says the workload for pharma regulatory affairs professionals has "dramatically increased." Release